Financings In Brief
This article was originally published in The Gray Sheet
Mentor: Santa Barbara, Calif. firm completes three-year syndicated credit agreement providing up to $200 mil. for pursuit of "licensing and acquisition opportunities" in markets where Mentor already competes, President & CEO Joshua Levine says. Bank of the West and Union Bank of California sponsored the agreement, which provides the option for a $50 mil. increase in the future. Separately, Mentor plans to launch its Hyalite non-animal stabilized hyaluronic acid, which it acquired through its 2003 purchase of A-life, in early 2006 (1"The Gray Sheet" May 30, 2005, p. 19). Hyalite will compete against Inamed's Hylaform avian-derived and Captique non-animal fillers, and Medicis' non-animal Restylane...
You may also be interested in...
Mentor plans to compete with Inamed in the hyaluronic acid (HA) dermal filler market, following an expected PMA approval of its Hyalite non-animal stabilized HA filler early 2006
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.